Cargando…
The pioneer and differentiation factor FOXA2 is a key driver of yolk‐sac tumour formation and a new biomarker for paediatric and adult yolk‐sac tumours
Yolk‐sac tumours (YSTs), a germ cell tumour subtype, occur in newborns and infants as well as in young adults of age 14‐44 years. In clinics, adult patients with YSTs face a poor prognosis, as these tumours are often therapy‐resistant and count for many germ cell tumour related deaths. So far, the m...
Autores principales: | Wruck, Wasco, Bremmer, Felix, Kotthoff, Mara, Fichtner, Alexander, Skowron, Margaretha A., Schönberger, Stefan, Calaminus, Gabriele, Vokuhl, Christian, Pfister, David, Heidenreich, Axel, Albers, Peter, Adjaye, James, Nettersheim, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875904/ https://www.ncbi.nlm.nih.gov/pubmed/33448076 http://dx.doi.org/10.1111/jcmm.16222 |
Ejemplares similares
-
CK19 is a sensitive marker for yolk sac tumours of the testis
por: Bremmer, Felix, et al.
Publicado: (2015) -
Post-menopausal presentation of yolk sac germ cell tumour
por: Parker, V.L., et al.
Publicado: (2014) -
Ovarian Yolk Sac Tumour in a Girl − Case Report
por: Sharma, Charu, et al.
Publicado: (2017) -
Targeting CLDN6 in germ cell tumors by an antibody-drug-conjugate and studying therapy resistance of yolk-sac tumors to identify and screen specific therapeutic options
por: Skowron, Margaretha A., et al.
Publicado: (2023) -
Mouse Yolk Sac Hematopoiesis
por: Yamane, Toshiyuki
Publicado: (2018)